BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8533490)

  • 1. [Interferon-alpha controls HPV infection in cervix epithelium].
    Labeit D; Labeit S; Berger M; Gallati H; Rosenberg R; Friese K
    Zentralbl Gynakol; 1995; 117(11):566-77. PubMed ID: 8533490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV.
    Passmore JA; Burch VC; Shephard EG; Marais DJ; Allan B; Kay P; Rose RC; Williamson AL
    J Med Virol; 2002 Jun; 67(2):234-40. PubMed ID: 11992584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferons and their receptors in human papillomavirus lesions of the uterine cervix.
    Cintorino M; Tripodi SA; Romagnoli R; Ietta F; Ricci MG; Paulesu L
    Eur J Gynaecol Oncol; 2002; 23(2):145-50. PubMed ID: 12013113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
    Welters MJ; de Jong A; van den Eeden SJ; van der Hulst JM; Kwappenberg KM; Hassane S; Franken KL; Drijfhout JW; Fleuren GJ; Kenter G; Melief CJ; Offringa R; van der Burg SH
    Cancer Res; 2003 Feb; 63(3):636-41. PubMed ID: 12566307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix.
    Song SH; Lee JK; Seok OS; Saw HS
    Gynecol Oncol; 2007 Mar; 104(3):732-8. PubMed ID: 17188341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific.
    Kadish AS; Romney SL; Ledwidge R; Tindle R; Fernando GJ; Zee SY; Van Ranst MA; Burk RD
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2277-84. PubMed ID: 8077925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P
    J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
    J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of human papillomavirus (HPV)-infected women: influence of HIV-1 coinfection.
    Nicol AF; Fernandes AT; Grinsztejn B; Russomano F; E Silva JR; Tristão A; Pérez Mde A; Nuovo GJ; Martínez-Maza O; Bonecini-Almeida Mda G
    Diagn Mol Pathol; 2005 Mar; 14(1):39-47. PubMed ID: 15714063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-Cadherin and CD44 expression in cervical intraepithelial neoplasia: comparison between HIV-positive and HIV-negative women and correlation with HPV status.
    Daraï E; Walker-Combrouze F; Bénifla JL; Hénin D; Feldmann G; Madelenat P; Scoazec JY
    Gynecol Oncol; 2000 Jan; 76(1):56-62. PubMed ID: 10620442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of local cell-mediated immunity in interferon-responsive patients with human papillomavirus-associated lesions.
    Arany I; Tyring SK
    J Interferon Cytokine Res; 1996 Jun; 16(6):453-60. PubMed ID: 8807499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
    de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
    Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytokine status of cervical mucus in women with transitory and persistent course of papillomavirus infection].
    Telesheva LF; Dolgushina VF; Abramovskikh OS; Zotova MA; Mezentseva EA; Orner IIu; Baturina IL; Akhmatova AN
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (4):118-21. PubMed ID: 22937720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations.
    Nonnenmacher B; Kruger Kjaer S; Svare EI; Scott JD; Hubbert NL; van den Brule AJ; Kirnbauer R; Walboomers JM; Lowy DR; Schiller JT
    Int J Cancer; 1996 Dec; 68(6):704-9. PubMed ID: 8980170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
    Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
    J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune cellular response to HPV: current concepts.
    Gonçalves MA; Donadi EA
    Braz J Infect Dis; 2004 Feb; 8(1):1-9. PubMed ID: 15137933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
    Petter A; Heim K; Guger M; Ciresa-Kö Nig A; Christensen N; Sarcletti M; Wieland U; Pfister H; Zangerle R; Höpfl R
    J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human papillomavirus infection and carcinogenesis of cancer of uterine cervix. II. Immunoperoxidase localization of papilloma-virus antigen in tissues of the uterine cervix].
    Shu LL; Yang XZ
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):430-2, 23. PubMed ID: 2838240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.